reThought Raises $15.5M in Series A Funding
02 Aug, 2021
– ISA Pharmaceuticals B.V. from Oegstgeest, The Netherlands closed a €26m funding round.
– Backers included new investor – Invest-NL and existing investors including Regeneron.
– The company intends to use the funds to advance the lead product ISA101b towards first marketing authorization as well as to broaden the clinical pipeline of immunotherapies based on the Synthetic Long Peptide (SLP®) platform technology.